This site uses cookies to make your web experience a great one.Learn More

The cookie settings on this website are currently set to allow certain types of cookies. We do not use cookies for targeted or behavioral advertising on this website. Those cookies that we do use are designed to permit you to use the site functions and browse our site in the way that is favorable to you. If you continue without changing your cookie settings, you consent to that. However, you can change your cookie setting at any time.

Proven Technology

Built on Clinical Performance

Persona Revision boasts the most clinically proven1-3 biological fixation portfolio on the market with over 20 years of successful clinical use. Combined with our premium bearing technology, Persona Revision Knee System provides customers with solutions to improve patient outcomes.

Trabecular Metal™ Material

Highly porous material is designed to replicate the structure, function and physiological properties of cancellous bone4

  • Made of commercially pure Tantalum
  • Published 0.98 coefficient of friction* against cancellous bone for initial stability 5
  • Engineered, open and interconnected pore structure with up to 80% porosity with 100% open-interconnected cell structure 4,5
  • Average pore size of 440 microns designed to support bony in-growth vascularization4,5

 

11

18

Vivacit-E® Vitamin-E Highly Crosslinked Polyethylene

Patients are expecting more out of the implants, and with that in mind, Persona Revision Bearings were created exclusively out of Vivacit-E Vitamin-E Highly Crosslinked Polyethylene. Vivacit-E polyethylene is actively stabilized with Vitamin-E to help protect against oxidation and maintain wear resistance and strength throughout the life of the implant. Results in a technologically advanced material that provides superior:

  • Exceptional Oxidative Stability6,7
  • Ultra-low Wear8,9
  • Enhanced Mechanical Strength10,11

 

*Laboratory results are not necessarily indicative of clinical performance.

Related Products

  1. Zhang, Y., et al. Interfacial Frictional Behavior: Cancellous Bone, Cortical Bone, and a Novel Porous Tantalum Biomaterial. Journal of Musculoskeletal Research. 3(4):, 245-251, 1999.
  2. Bobyn, J.D., et al. Characteristics of Bone In-growth and Interface Mechanics of a New Porous Tantalum Biomaterial. Journal of Bone and Joint Surgery (British). 81-B(5): 907, 1999.
  3. Shirazi-Adl, A., et al. Experimental Determination of Friction Characteristics at the Trabecular Bone / Porous-coated Metal Interface in Cementless Implants. The Journal of Biomedical Research. 27: 167-175, 1993.
  4. Bobyn, J.D., et al. Characterization of New Porous Tantalum Biomaterial for Reconstructive Orthopaedics. Scientific Exhibition. 66th Annual Meeting of the American Academy of Orthopaedic Surgeons. Anaheim, CA. 1999.
  5. Karageorgiou V, Kaplan D. Porosity of biomaterial scaffolds and osteogenesis. Biomaterials. 26: 5474-5491, 2005.
  6. Internal Data on File at Zimmer Biomet. Zimmer ZRR_WA_2409_11. 2011.
  7. Internal Data on File at Zimmer Biomet Zimmer ZRR_WA_2403_11. 2011.
  8. Internal Data on File at Zimmer Biomet Zimmer ZRR_WA_2537_12. 2012.
  9. Internal Data on File at Zimmer Biomet Zimmer ZTR_BI_0249_18. 2018.
  10. Internal Data on File at Zimmer Biomet Zimmer ZRR_WA_2551_12. 2012.
  11. Internal Data on File at Zimmer Biomet Zimmer ZTR_BI_0133_18. 2018.
All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert and information on this website. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please call 1-800-348-2759, press 4 for 411 Technical Support.